Updated 6 May 2014

The World Federation is proud to congratulate Dr. Mohammed Murtaza on his selection a Post-Doctoral Scholar at Arizona State University.  Dr. Muhammad will be an early career scholar at Translational Genomics Research Institute.  Considered as one of the top science and engineering talents, he has been recognized and awarded an early-career tenure track faculty for its prestigious Bisgrove Scholars Award: 

SCIENCE FOUNDATION ARIZONA SELECTS TOP SCIENCE AND ENGINEERING TALENT TO LEAD RESEARCH AT ARIZONA INSTITUTIONS THROUGH BISGROVE SCHOLAR PROGRAM

PHOENIX (April 23, 2014) – Science Foundation Arizona (SFAz) announces the selection of four nationally and internationally recognized Ph.D. candidates and early-career tenure track faculty for its prestigious Bisgrove Scholars award. Arizona’s top research institutions will receive new scholars and research funding by fall 2014.

The four selected for the 2014 Bisgrove Scholars Award are Michael Gram who will be a Post-Doctoral Scholar at Arizona State University (ASU), Dr. Muhammad Murtaza who will be an Early Career Scholar at Translational Genomics Research Institute (TGen), Cody Routson who will be a Post-Doctoral Scholar at Northern Arizona University (NAU) and Rachel Rowe who will be a Post-Doctoral Scholar at Phoenix Children’s Hospital (PCH):

Dr. Muhammad Murtaza, an early career scholar with a focus on tumor DNA analysis will begin his Bisgrove fellowship at TGen and the Mayo Clinic after he completes his graduate studies at Trinity College, University of Cambridge, England this summer. He has already completed dual degrees in medicine and surgery from Aga Khan University, Pakistan.  Murtaza has published groundbreaking research in Nature and the New England Journal of Medicine on using circulating tumor-specific DNA to measure changes in tumors and to understand how cancers evolve in response to treatment. At TGen and the Mayo Clinic, Scottsdale, he will continue this work and co-lead the setup of a program focused on increasing the understanding of the issues while seeking clinical application of circulating tumor DNA analysis, applying methods in genomics and bioinformatics.  This research could potentially lead to circulating DNA-based cancer blood tests for human patients allowing better disease tracking and more informed treatment decisions.

Congratulations on your tremendous accomplishment.  We pray for your success and look forward to hearing of your further achievements!